X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (31410) 31410
Magazine Article (86) 86
Newspaper Article (39) 39
Book Chapter (31) 31
Newsletter (21) 21
Book / eBook (18) 18
Conference Proceeding (6) 6
Dissertation (6) 6
Government Document (6) 6
Book Review (3) 3
Publication (3) 3
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (20798) 20798
male (17431) 17431
animals (13376) 13376
female (12241) 12241
kidney diseases - chemically induced (11029) 11029
rats (7635) 7635
middle aged (7497) 7497
adult (6134) 6134
aged (5502) 5502
kidney - drug effects (4883) 4883
urology & nephrology (4340) 4340
acute kidney injury - chemically induced (4159) 4159
kidney - pathology (3912) 3912
risk factors (3357) 3357
mice (3335) 3335
pharmacology & pharmacy (3014) 3014
disease models, animal (2802) 2802
kidney - metabolism (2763) 2763
kidneys (2591) 2591
kidney (2579) 2579
nephrotoxicity (2579) 2579
creatinine - blood (2573) 2573
kidney diseases (2518) 2518
time factors (2364) 2364
kidney diseases - pathology (2295) 2295
toxicology (2209) 2209
contrast media - adverse effects (2207) 2207
rats, sprague-dawley (2078) 2078
rats, wistar (2058) 2058
oxidative stress (2022) 2022
kidney transplantation (1924) 1924
dose-response relationship, drug (1879) 1879
kidney diseases - prevention & control (1878) 1878
toxicity (1783) 1783
treatment outcome (1771) 1771
retrospective studies (1706) 1706
adolescent (1693) 1693
transplantation (1692) 1692
medicine, general & internal (1568) 1568
nephrology (1436) 1436
oncology (1433) 1433
expression (1428) 1428
kidney function tests (1418) 1418
hypertension (1402) 1402
acute kidney injury (1391) 1391
aged, 80 and over (1382) 1382
disease (1372) 1372
immunosuppressive agents - adverse effects (1372) 1372
health aspects (1334) 1334
therapy (1323) 1323
research (1317) 1317
child (1308) 1308
analysis (1301) 1301
rodents (1292) 1292
kidney diseases - metabolism (1280) 1280
cancer (1257) 1257
kidney - physiopathology (1253) 1253
care and treatment (1213) 1213
research article (1208) 1208
acute-renal-failure (1202) 1202
risk (1197) 1197
inflammation (1184) 1184
mortality (1174) 1174
hypertension - chemically induced (1154) 1154
apoptosis (1151) 1151
immunology (1134) 1134
liver (1131) 1131
surgery (1125) 1125
prospective studies (1124) 1124
physiology (1120) 1120
glomerular filtration rate (1108) 1108
kidney diseases - physiopathology (1077) 1077
medicine & public health (1076) 1076
peripheral vascular disease (1031) 1031
prevention (1031) 1031
oxidative stress - drug effects (1006) 1006
nephropathy (994) 994
incidence (973) 973
cardiac & cardiovascular systems (968) 968
medicine (964) 964
renal dialysis (947) 947
liver - drug effects (933) 933
anti-bacterial agents - adverse effects (930) 930
antineoplastic agents - adverse effects (925) 925
diabetes (925) 925
acute disease (913) 913
follow-up studies (912) 912
proteins (905) 905
blood urea nitrogen (884) 884
chronic kidney-disease (872) 872
drug therapy, combination (868) 868
mice, inbred c57bl (865) 865
cisplatin (856) 856
injury (855) 855
biochemistry & molecular biology (851) 851
blood pressure - drug effects (848) 848
fibrosis (844) 844
cells (842) 842
risk assessment (840) 840
abridged index medicus (838) 838
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (28997) 28997
French (615) 615
German (593) 593
Japanese (537) 537
Spanish (257) 257
Russian (249) 249
Italian (214) 214
Chinese (197) 197
Polish (127) 127
Danish (50) 50
Dutch (42) 42
Portuguese (35) 35
Czech (33) 33
Hungarian (28) 28
Swedish (25) 25
Norwegian (24) 24
Finnish (14) 14
Croatian (12) 12
Slovak (12) 12
Bulgarian (11) 11
Serbian (10) 10
Ukrainian (9) 9
Hebrew (8) 8
Romanian (7) 7
Turkish (6) 6
Korean (3) 3
Lithuanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of the American College of Cardiology, ISSN 0735-1097, 2016, Volume 67, Issue 20, pp. 2395 - 2410
.... SAMS is the most frequent SAS, and mild myalgia may affect 5% to 10% of statin users. Clinically important muscle symptoms, including rhabdomyolysis and statin-induced necrotizing autoimmune myopathy... 
Cardiovascular | Internal Medicine | rhabdomyolysis | skeletal muscle | interstitial lung disease | myopathy | C-REACTIVE PROTEIN | RANDOMIZED CONTROLLED-TRIALS | CARDIAC & CARDIOVASCULAR SYSTEMS | FORCE 2014 UPDATE | PRIMARY-PREVENTION TRIAL | INDUCED MUSCLE TOXICITY | INTERSTITIAL LUNG-DISEASE | CENTRAL-NERVOUS-SYSTEM | OF-THE-LITERATURE | CORONARY-HEART-DISEASE | TYPE-2 DIABETES-MELLITUS | Liver Function Tests | Sleep Wake Disorders - chemically induced | Hydroxymethylglutaryl-CoA Reductase Inhibitors - immunology | Myalgia - chemically induced | Humans | Hyperlipidemias - drug therapy | Risk Factors | Lung Diseases, Interstitial - chemically induced | Tendon Injuries - chemically induced | Necrosis - chemically induced | Brain - drug effects | Rupture - chemically induced | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Stroke - chemically induced | Cognition Disorders - etiology | Depression - chemically induced | Rhabdomyolysis - chemically induced | Antibodies - blood | Diabetes Mellitus - chemically induced | Acute Kidney Injury - chemically induced | Muscular Diseases - chemically induced | Testosterone - blood | Autoimmune Diseases - chemically induced | Hyperlipidemias - complications | Viral antibodies | Complications and side effects | Enzymes | Thiols | Antibodies | Diabetes | Cardiology | Statins | Cardiovascular agents | Creatine kinase | Muscles | Creatine | Respiratory tract diseases | Studies | Musculoskeletal system | Genotype & phenotype | Mortality | Clinical trials | Lipids | Clinical medicine
Journal Article
Journal Article
Medical Clinics of North America, ISSN 0025-7125, 07/2010, Volume 94, Issue 4, pp. 743 - 759
Journal Article
BMJ : British Medical Journal, ISSN 1756-1833, 7/2014, Volume 349, Issue jul17 11, pp. g3743 - g3743
Statins form the pharmacologic cornerstone of the primary and secondary prevention of atherosclerotic cardiovascular disease... 
STATE OF THE ART REVIEW | LDL CHOLESTEROL | ACUTE KIDNEY INJURY | MEDICINE, GENERAL & INTERNAL | MYOCARDIAL-INFARCTION | PULMONARY-HYPERTENSION | RANDOMIZED CONTROLLED-TRIAL | PLACEBO-CONTROLLED TRIAL | CORONARY-HEART-DISEASE | AVERAGE CHOLESTEROL LEVELS | OF-THE-LITERATURE | ERECTILE DYSFUNCTION | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Meta-Analysis as Topic | Cataract - chemically induced | Erectile Dysfunction - chemically induced | Humans | Male | Fatigue - chemically induced | Pancreatitis - prevention & control | Hypercholesterolemia - drug therapy | Transaminases - analysis | Organic Anion Transporters - genetics | Contrast Media - adverse effects | Neoplasms - chemically induced | Kidney Diseases - chemically induced | Acute Kidney Injury - chemically induced | Muscular Diseases - chemically induced | Genetic Predisposition to Disease | Kidney Diseases - prevention & control | Risk Factors | Clinical Trials as Topic | Cognition - drug effects | Liver - chemistry | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Dementia - chemically induced | Venous Thromboembolism - chemically induced | Diabetes Mellitus - chemically induced | Chemical and Drug Induced Liver Injury | Polymorphism, Single Nucleotide | Muscular Diseases - genetics | Solute Carrier Organic Anion Transporter Family Member 1b1 | Research Design | Pulmonary Disease, Chronic Obstructive - drug therapy
Journal Article
The Lancet. Haematology, ISSN 2352-3026, 2016, Volume 3, Issue 5, pp. e217 - e227
Summary Background Standard treatment for patients with primary CNS lymphoma remains to be defined. Active therapies are often associated with increased risk... 
Hematology, Oncology and Palliative Medicine | 1ST-LINE TREATMENT | RESPONSE CRITERIA | GUIDELINES | NON-HODGKINS-LYMPHOMA | FOLLOW-UP | CENTRAL-NERVOUS-SYSTEM | WHOLE-BRAIN RADIOTHERAPY | HIGH-DOSE CHEMOTHERAPY | STEM-CELL TRANSPLANTATION | HEMATOLOGY | Follow-Up Studies | Cytarabine - therapeutic use | Humans | Lymphoma, B-Cell - therapy | Middle Aged | Male | Comparative Effectiveness Research | Hyperglycemia - chemically induced | Radiotherapy, Adjuvant - adverse effects | Hematopoietic Stem Cell Transplantation - adverse effects | Lymphoma, B-Cell - diagnostic imaging | Transplantation Conditioning - methods | Rituximab - adverse effects | Induction Chemotherapy - methods | Anemia - chemically induced | Central Nervous System Neoplasms - therapy | Thrombocytopenia - chemically induced | Mucositis - chemically induced | Magnetic Resonance Imaging | Methotrexate - adverse effects | Dexamethasone - therapeutic use | Radiotherapy, Adjuvant - methods | Transplantation, Autologous - adverse effects | Heart Injuries - chemically induced | Italy | Hematopoietic Stem Cell Transplantation - methods | Central Nervous System Neoplasms - mortality | Germany | Thiotepa - adverse effects | Thiotepa - therapeutic use | Thrombosis - chemically induced | Infections - chemically induced | Intraocular Lymphoma - therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Cytarabine - adverse effects | Methotrexate - therapeutic use | Rituximab - therapeutic use | Stroke - chemically induced | Optic Nerve Neoplasms - diagnostic imaging | Poisoning - epidemiology | Female | Remission Induction - methods | Transplantation Conditioning - adverse effects | Acute Kidney Injury - chemically induced | Neutropenia - chemically induced | Optic Nerve Neoplasms - therapy | Death, Sudden - epidemiology | Lymphoma, B-Cell - mortality | Intraocular Lymphoma - diagnostic imaging | Kaplan-Meier Estimate | Chemical and Drug Induced Liver Injury - epidemiology | Treatment Outcome | United Kingdom | Combined Modality Therapy - adverse effects | Switzerland | Induction Chemotherapy - adverse effects | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Central Nervous System Neoplasms - diagnostic imaging | Denmark | Combined Modality Therapy - methods | Neurotoxicity Syndromes - epidemiology | Gastrointestinal Diseases - chemically induced
Journal Article
The lancet oncology, ISSN 1470-2045, 2017, Volume 18, Issue 6, pp. 770 - 778
... 50% of patients presenting with metastatic disease. Metabolic reprogramming is an emerging hallmark of pancreatic adenocarcinoma... 
Hematology, Oncology and Palliative Medicine | ONCOLOGY | MITOCHONDRIAL METABOLISM | Leucovorin - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Sulfides - administration & dosage | Pancreatic Neoplasms - drug therapy | Organoplatinum Compounds - administration & dosage | Fluorouracil - administration & dosage | Hyperglycemia - chemically induced | Leucovorin - adverse effects | Fluorouracil - adverse effects | Hypokalemia - chemically induced | Camptothecin - administration & dosage | Female | Neutropenia - chemically induced | Camptothecin - analogs & derivatives | Camptothecin - adverse effects | Hematologic Diseases - chemically induced | Sensation Disorders - chemically induced | Abdominal Pain - chemically induced | Pancreatic Neoplasms - pathology | Anemia - chemically induced | Thrombocytopenia - chemically induced | Adenocarcinoma - drug therapy | Adenocarcinoma - secondary | Hypoalbuminemia - chemically induced | Maximum Tolerated Dose | Sepsis - chemically induced | Sulfides - adverse effects | Aged | Caprylates - administration & dosage | Caprylates - adverse effects | Organoplatinum Compounds - adverse effects | Lymphopenia - chemically induced | Enzymes | Medical colleges | Care and treatment | Metastasis | Antineoplastic agents | Cells | Antimitotic agents | Cancer patients | Chemotherapy | Pancreatic cancer | Physiological aspects | Product development | Cancer
Journal Article
Journal Article
Circulation, ISSN 0009-7322, 03/2007, Volume 115, Issue 12, pp. 1634 - 1642
Drugs | Cyclooxygenase 2 inhibitors | Aspirin | Inhibitors | Coxibs | Antiinflammatory agents, nonsteroidal | AHA Scientific Statements | inhibitors | CARDIAC & CARDIOVASCULAR SYSTEMS | cyclooxygenase 2 inhibitors | METAANALYSIS | PUBLIC-HEALTH | drugs | CARDIOVASCULAR EVENTS | ATHEROSCLEROSIS | RISK | coxibs | BLOOD-PRESSURE | antiinflammatory agents, nonsteroidal | LOW-DOSE ASPIRIN | CYCLOOXYGENASE INHIBITION | MOUSE MODEL | aspirin | PERIPHERAL VASCULAR DISEASE | COX-2 INHIBITORS | Analgesics - pharmacology | Thrombosis - chemically induced | Analgesics - classification | United States | Cardiovascular Diseases - prevention & control | Humans | Anti-Inflammatory Agents, Non-Steroidal - pharmacology | Cardiotonic Agents - therapeutic use | Cyclooxygenase 2 Inhibitors - adverse effects | Drug Interactions | Stroke - chemically induced | Pain - drug therapy | Hypertension - chemically induced | Cyclooxygenase 2 Inhibitors - therapeutic use | Kidney Diseases - chemically induced | Platelet Aggregation Inhibitors - pharmacology | Thrombosis - prevention & control | Platelet Aggregation Inhibitors - therapeutic use | United States Food and Drug Administration | Analgesics - adverse effects | Analgesics - therapeutic use | Duty to Warn | Musculoskeletal Diseases - drug therapy | Stroke - prevention & control | Prostaglandin Antagonists - therapeutic use | Cardiotonic Agents - pharmacology | Prostaglandin Antagonists - adverse effects | Randomized Controlled Trials as Topic | Gastrointestinal Hemorrhage - chemically induced | Gastrointestinal Hemorrhage - prevention & control | Drug Labeling | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Cardiovascular Diseases - chemically induced | Disease Management | Edema - chemically induced | Anti-Inflammatory Agents, Non-Steroidal - classification | COX-2 inhibitors | Complications and side effects | Dosage and administration | Nonsteroidal anti-inflammatory drugs | Cardiovascular diseases | Risk factors | Cerebrovascular disease
Journal Article
Journal Article
American Journal of Transplantation, ISSN 1600-6143, 06/2010, Volume 10, Issue 6, pp. 1420 - 1427
Journal Article